SCHEMBL24314247

SCHEMBL24314247

CCOc1ccc(C2CC2)cc1S(=O)(=O)NC(=O)c1cc2c(F)cc(C3CC3)cc2o1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
TRIM24 O15164 2/20 0.36
TSHR P16473 2/20 0.36
LMNA P02545 4/20 0.35
KDM1A O60341 2/20 0.35
MAPT P10636 2/20 0.35
HTT P42858 2/20 0.35
CCR5 P51681 2/20 0.35
ALDH1A1 P00352 3/20 0.34
KDM4E B2RXH2 1/20 0.34
KAT7 O95251 1/20 0.34
KAT6B Q8WYB5 1/20 0.34
KAT6A Q92794 1/20 0.34
KAT5 Q92993 1/20 0.34
KAT8 Q9H7Z6 1/20 0.34
CYP2C8 P10632 1/20 0.34
PTGDR Q13258 1/20 0.34
PTGDR2 Q9Y5Y4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24314237 0.94 MRGPRX1 (0.38) MEN1KMT2AL3MBTL1TSHRKAT6A
SCHEMBL24313753 0.91 MEN1 (0.38) MEN1KMT2AL3MBTL1TSHRLMNA
SCHEMBL24313760 0.91 SCN9A (0.35) MEN1KMT2AL3MBTL1TSHRLMNA
SCHEMBL24314300 0.91 ALDH1A1 (0.38) MEN1KMT2AL3MBTL1TSHRLMNA
SCHEMBL24313686 0.91 ALDH1A1 (0.44) MEN1KMT2AL3MBTL1TSHRLMNA
SCHEMBL24313979 0.91 CYP1A2 (0.37) MEN1KMT2AL3MBTL1TSHRLMNA
SCHEMBL24313774 0.90 TRIM24 (0.41) MEN1KMT2AL3MBTL1TRIM24LMNA
SCHEMBL24314309 0.89 SCN7A (0.37) MEN1KMT2AL3MBTL1ALDH1A1
SCHEMBL24314230 0.89 MEN1 (0.36) MEN1KMT2ALMNAMAPTHTT
SCHEMBL24313659 0.89 MRGPRX1 (0.36) MEN1KMT2AL3MBTL1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4229045-B1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER BROAD INST INC (US) 2025-11-12 EP claimed
EP-4229045-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute Inc. (US) 2023-08-23 EP claimed
WO-2022081842-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO claimed
EP-4229045-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute Inc. (US) 2023-08-23 EP disclosed
WO-2022081842-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed
WO-2022081842-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed